As of 2024-12-13, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.09) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -319.7%.
The range of the Relative Valuation is (0.89) - (1.27) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 10.3x | 8.6x |
| Forward P/E multiples | 7.3x - 10.9x | 9.1x |
| Fair Price | (0.89) - (1.27) | (1.09) |
| Upside | -280.7% - -356.2% | -319.7% |
| Date | P/E |